Please try another search
Asia Green Biotechnology Corp., an early stage international agro-technology company, focuses on the development, evaluation, testing, application, and supply of products derived from proprietary organic hybridization technology. The company focuses on planting, growing, and harvesting new and valuable strains of hemp and related crops. It has an agreement with Pathway Rx and PNW Biosciences Inc. for the clinical development and commercialization of the cannabis sativa varieties for prevention and treatment of COVID-19 and other infectious diseases. The company was formerly known as Asia Cannabis Corp. and changed its name to Asia Green Biotechnology Corp. in April 2020. Asia Green Biotechnology Corp. was incorporated in 2017 and is based in Calgary, Canada.
Name | Age | Since | Title |
---|---|---|---|
David Edward-Thomas Pinkman | 66 | 2018 | CEO, President, Corporate Secretary & Director |
Igor Kovalchuk | 54 | 2018 | Independent Director |
Alisdair Leeson | - | 2019 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review